CLINICAL ROLE -
Bacteria Involved in Slow Healing Wounds
Approximately 1 in 10 people will experience a poorly healing wound, which can lead to amputations in patients with diabetes.
Read More
Nerves May Sustain Prostate Cancer Progression
Norepinephrine may increase blood vessel growth in prostate cancer tumors.
Trending News Today: Open Enrollment 2018 Kicks Off
Top news of the day from across the healthcare landscape.
Trending News Today: Proposed Legislation Aims to Reduce Medical Waste
How Pharmacogenetics Influence Antiviral Therapy for HIV
Human genome sequence variations can have a significant impact on the efficacy of HIV antiviral therapy.
Study Compares Duration of Dual Antiplatelet Therapy in Acute Coronary Syndrome
Recent guidelines recommend 6-12 months of dual antiplatelet therapy for patients with stable angina treated with a new generation drug-eluting stent.
Fish and Fish Oil Equally Protective Against Childhood Asthma?
FDA Committee Gives Thumbs Up to Opioid Use Disorder Treatment
Psychopharmacologic Drugs Advisory Committee and Drug Safety and Risk Management votes 18-1 to approve investigational once-monthly injectable buprenorphine formulation.
Pharmacy Times and Specialty Pharmacy Times Kick Off #APharmacistIs Social Media Campaign
Even beyond American Pharmacists Month, pharmacists deserve to be recognized for the important role they play in patient care.
Pharmacy Times and Specialty Pharmacy Times Launch #APharmacistIs Campaign
The #APharmacistIs campaign aims to increase awareness about the value of pharmacists.
Novartis Seeks New Indication for Gene Therapy Kymriah
Tisagenlecleucel (Kyrmiah) shows promise as a treatment for diffuse large B-cell lymphoma.
Hepatitis C: A Comprehensive Overview of Effective Treatment Options
Many new antiviral drugs that treat hepatitis C have similar efficacy, but come with different advantages and disadvantages.
FDA Advisory Committee Recommends Approval of Opioid Use Disorder Treatment
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2017.
HIV Negatively Affects Children's Brains Despite Treatment
HIV-positive children administered antiretroviral therapy have changes in their white matter brain tissue.
FDA Highlights New Strategies to Combat the Opioid Epidemic
Novel methods to package, store, and dispose of opioids could fight the ongoing epidemic.
Therapeutic Arsenic Effective Against Glioblastoma
The addition of arsenic trioxide to standard therapy could triple glioblastoma survival.
Brain Glucose Levels Drop in Patients with Obesity, Diabetes
Low brain glucose levels may result in overeating among patients with obesity and type 2 diabetes.
Trending News Today: Generic Drug Pricing Lawsuit Expands
Trending News Today: Proton Pump Inhibitors May Increase Stomach Cancer Risk in Certain Patients
Antiretroviral Therapy for HIV: Pharmacogenetic Considerations
Pharmacists can expect to see considerably more information about the implications of pharmacogenetics for drug treatment in every disease state.
Dupixent Shows Consistent Efficacy Treating Asthma Attacks
Dupilumab is a monoclonal antibody previously approved to treat moderate-to-severe atopic dermatitis.
FDA Seeks to Improve Global Pharmaceutical Manufacturing Inspections
Some therapies approved in the United States are either fully manufactured overseas or made domestically but contain some foreign ingredients.
Pneumococcal Vaccination: Public Outreach Makes Significant Difference
Sixty-seven million at-risk Americans remain unvaccinated for pneumococcal disease
505 (b)(2) Regulatory Pathway for New Drug Approvals
It takes a great deal of time and resources for a manufacturer to complete all the necessary requirements to submit a successful NDA to the FDA for review.
How to Fit In Fitness For A Busy Pharmacy Professional
Pharmacists don't have much free time, but it won't take much to make fitness a mainstay with this slick technique.
FDA Takes Step Toward Additional Global Pharmaceutical Manufacturing Inspections
In June 2017, the European Commission determined that the FDA “has the capability, capacity and procedures in place to carry out GMP inspections at a level equivalent to the EU.”
Mantle Cell Lymphoma Drug Gets FDA OK
The application for acalabrutinib in mantle cell lymphoma was previously granted priority review, breakthrough therapy, and orphan drug designations, according to the FDA.
PCSK9 Inhibitors Have High Prior Authorization Rejection Rate
Medicare-insured patients with heart disease had the greatest access to PCSK9 inhibitors.
FDA Grants Accelerated Approval to Acalabrutinib for Mantle Cell Lymphoma
Calquence is a kinase inhibitor that blocks an enzyme crucial for cancer growth.
Mantle Cell Lymphoma Drug Receives FDA Approval
Acalabrutinib (Calquence) found to improve overall response rate among patients with mantle cell lymphoma.
